Advertisement
Research Article Free access | 10.1172/JCI112727
Find articles by Dullaart, R. in: JCI | PubMed | Google Scholar
Find articles by Speelberg, B. in: JCI | PubMed | Google Scholar
Find articles by Schuurman, H. in: JCI | PubMed | Google Scholar
Find articles by Milne, R. in: JCI | PubMed | Google Scholar
Find articles by Havekes, L. in: JCI | PubMed | Google Scholar
Find articles by Marcel, Y. in: JCI | PubMed | Google Scholar
Find articles by Geuze, H. in: JCI | PubMed | Google Scholar
Find articles by Hulshof, M. in: JCI | PubMed | Google Scholar
Find articles by Erkelens, D. in: JCI | PubMed | Google Scholar
Published November 1, 1986 - More info
The presence of apolipoprotein (apo) B in liver and intestine from a patient with abetalipoproteinemia was evaluated by immunohistochemistry with a polyclonal and six monoclonal antibodies to different apo B-48 and B-100 epitopes. In normal liver, apo B was present inside and outside hepatocytes. The patients liver exhibited staining in the cytoplasm with the polyclonal and three monoclonal antibodies. By immunoelectron-microscopy, apo B was found to be present in the smooth endoplasmatic reticulum and the Golgi complex. Normal intestinal epithelium was labeled with polyclonal and all monoclonal antibodies, including those specific for apo B-100. The patients epithelium stained with polyclonal and six monoclonals, and apo B was present in the Golgi complex. Thus, normal intestinal mucosa expressed apo B-48 and B-100 epitopes, which indicates apo B-100 synthesis in the gut. The synthesis of the apo B molecule in the patient seems to be retained in both liver and gut, which suggests a posttranslational defect.
Images.